118 related articles for article (PubMed ID: 5415210)
1. Semisynthetic coumermycins: structure-activity relationships.
Price KE; Chisholm DR; Godfrey JC; Misiek M; Gourevitch A
Appl Microbiol; 1970 Jan; 19(1):14-26. PubMed ID: 5415210
[TBL] [Abstract][Full Text] [Related]
2. Semisynthetic coumermycins. VI. Preparation and properties of 3-(3-aryl- and 3-aralkyl-4-hydroxybenzamido)-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy]coumarins.
Schmitz H; Godfrey JC
J Antibiot (Tokyo); 1970 Oct; 23(10):497-501. PubMed ID: 5482760
[No Abstract] [Full Text] [Related]
3. Semisynthetic coumermycins. II. Preparation and properties of 3-(substituted benzamido)-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy] coumarins.
Schmitz H; DeVault RL; McDonnell CD; Godfrey JC
J Antibiot (Tokyo); 1968 Oct; 21(10):603-10. PubMed ID: 5715670
[No Abstract] [Full Text] [Related]
4. Preparation of semisynthetic coumermycin A1 derivatives. IV. Aliphatic acyl and related derivatives of 3-amino-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl) noviosyloxy] coumarin.
Keil JG; Hooper IR; Schreiber RH; Swanson CL; Godfrey JC
Antimicrob Agents Chemother (Bethesda); 1969; 9():200-8. PubMed ID: 5396488
[No Abstract] [Full Text] [Related]
5. Preparation of semisynthetic coumermycin A1 derivatives. 3. Aromatic and heteroaromatic derivatives of 3-amino-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl) noviosyloxy]coumarin.
Keil JG; Hooper IR; Cron MJ; Schmitz H; Nettleton DE; Godfrey JC
Antimicrob Agents Chemother (Bethesda); 1968; 8():120-7. PubMed ID: 4390419
[No Abstract] [Full Text] [Related]
6. Semisynthetic coumermycins. I. Preparation of 3-acylamido-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy]coumarins.
Keil JG; Hooper IR; Cron MJ; Farbig OB; Nettleton DE
J Antibiot (Tokyo); 1968 Sep; 21(9):551-66. PubMed ID: 5716315
[No Abstract] [Full Text] [Related]
7. Pyrrole antibacterial agents. 1. Compounds related to pyoluteorin.
Bailey DM; Johnson RE; Salvador UJ
J Med Chem; 1973 Nov; 16(11):1298-300. PubMed ID: 4201184
[No Abstract] [Full Text] [Related]
8. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
[TBL] [Abstract][Full Text] [Related]
11. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
[TBL] [Abstract][Full Text] [Related]
12. 14Alpha, 17 alpha-alkylidenedioxy steroids. 2. 19-Nor-9 alpha, 10 beta- and 19-nor-9 beta, 10 alpha-progesterone analogs.
Marx AF; Kooreman HJ; Jaitly KD; van der Sijde D
J Med Chem; 1973 Nov; 16(11):1300-2. PubMed ID: 4201185
[No Abstract] [Full Text] [Related]
13. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Utsui Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
Lepak AJ; Andes DR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary antimicrobial evaluation of new 7-(N-pyrrolyl) derivatives of cephalosporins.
Bijev A; Nankov A; Keuleyan E; Markovska R; Daneva E
Arzneimittelforschung; 2004; 54(2):119-24. PubMed ID: 15038462
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships in coumermycins.
Godfrey JC; Price KE
Adv Appl Microbiol; 1972; 15():231-96. PubMed ID: 4593293
[No Abstract] [Full Text] [Related]
17. Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.
Yamane T; Hashizume T; Yamashita K; Konishi E; Hosoe K; Hidaka T; Watanabe K; Kawaharada H; Yamamoto T; Kuze F
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):148-55. PubMed ID: 8448815
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimicrobial activity of some pyrrole derivatives. III--2-(4-arylpiperazino)-3-ethoxycarbonyl-5-aryl-pyrrole derivatives.
Cocco MT; Congiu C; Maccioni A; Schivo ML; De Logu A; Palmieri G
Farmaco Sci; 1988 Dec; 43(12):951-60. PubMed ID: 3248594
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Fernandes PB; Chu DT; Bower RR; Jarvis KP; Ramer NR; Shipkowitz N
Antimicrob Agents Chemother; 1986 Feb; 29(2):201-8. PubMed ID: 3521473
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model.
Andes D; Craig WA
Antimicrob Agents Chemother; 2003 Dec; 47(12):3935-41. PubMed ID: 14638504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
